Yeh – and that ties back into this idea "target trial emulation" is somehow a valid approach. Patient may superficially appear to be identical at the time of "enrollment", but undetected selection factors influence which patients receive which treatment.
Not a lot of takeaways here, other than to see a general absence of a signal of severe harm in the cohort with rapid correction.
Yeh – and that ties back into this idea "target trial emulation" is somehow a valid approach. Patient may superficially appear to be identical at the time of "enrollment", but undetected selection factors influence which patients receive which treatment.
Not a lot of takeaways here, other than to see a general absence of a signal of severe harm in the cohort with rapid correction.